Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a rare disease therapeutics company, today provided corporate updates and reported its financial results for the fourth quarter and year ended December 31, 2023.
In addition to analyzing a company's bottom line for profitability, there has been a push by some to measure its impact on society and the environment. Hence, the concept of thetriple bottom line (TBL)was born. TBL focuses on profit, people, and the planet. The TBL theory suggests that ...
In connection with the transaction, TD Waterhouse Canada acquired 100% of Ameritrade's Canadian brokerage operations for $77 million cash consideration. Pursuant to the terms of the TD Ameritrade Stockholders Agreement, the Bank's beneficial ownership of TD Ameritrade is currently limited to 39.9% ...
Inc. (NasdaqGS: ZVRA) (Zevra or the Company), a rare disease therapeutics company, today announced the completion of its acquisition ofAcer Therapeutics Inc.(Acer) which marks a significant step forward in executing Zevra’s strategy to become a ...
A Corporation must file its own income tax return (IRS Form 1120). The company receives deductions for business expenses, which reduces its tax liability when it earns revenue. It may not be deducted as an expense money paid to stockholders as dividends, and the individual stockholders who rece...